AngioDynamics

ANGIODYNAMICS INC

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Gold,Bar,On,Candlestick,Chart,Background.,Conceptual,Image,Of,Gold

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ANGO

CNTM

NCNO

SYRA

Gold Moves Higher; US Private Sector Job Growth Tops Estimates

Richmond,,Virginia,,Usa,-,9,May,2019:,Illustrative,Editorial,Of

Guidance

Health Care

Movers

General

AngioDynamics raised its fiscal 2025 sales outlook to $285M-$288M and boosted its adjusted EBITDA forecast, expecting stronger Med Tech revenue growth.

Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance

Gamestop, Lululemon, Uber, Ulta Beauty And Tesla: Why These 5 Stocks Are On Investors' Radars Today

ACLX

ALGT

CGNT

CIEN

COOP

CRWV

CYTK

GYRE

RDFN

SANA

Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday

AngioDynamics Inc

ANGO WORLD HOLDINGS INC by ANGO World Holdings, Inc.

Angold Resources Ltd Ordinary Shares

Press Releases

AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results

AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI

AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia

AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference

AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event

AngioDynamics to Host Virtual Cardiovascular Investor Event

AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results

Axogen

Beta Bionics

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

BrainsWay Ltd. - American Depositary Shares

BrainsWay

CeriBell

ClearPoint Neuro

CVRx

Delcath Systems

Alpha Tau Medical

iRadimed

NeuroPace

Orthofix Medical

Outset Medical

Senseonics Holdings

SI-BONE

Semler Scientific

SANUWAVE Health

Surmodics

Neuronetics

Stereotaxis

Tactile Systems Technology, Inc. - Common Stock

Tactile Systems Tech

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

Varex Imaging

ZimVie

HC Wainwright & Co.

Canaccord Genuity

Oppenheimer

Raymond James

Comments

AngioDynamics

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell